Literature DB >> 8651292

A mutation causing Alport syndrome with tardive hearing loss is common in the western United States.

D F Barker1, C J Pruchno, X Jiang, C L Atkin, E M Stone, J C Denison, P R Fain, M C Gregory.   

Abstract

Mutations in the COL4A5 gene, located at Xq22, cause Alport syndrome (AS), a nephritis characterized by progressive deterioration of the glomerular basement membrane and usually associated with progressive hearing loss. We have identified a novel mutation, L1649R, present in 9 of 121 independently ascertained families. Affected males shared the same haplotype of eight polymorphic markers tightly linked to COL4A5, indicating common ancestry. Genealogical studies place the birth of this ancestor >200 years ago. The L1649R mutation is a relatively common cause of Alport syndrome in the western United States, in part because of the rapid growth and migratory expansion of mid-nineteenth-century pioneer populations carrying the gene. L1649R affects a highly conserved residue in the NC1 domain, which is involved in key inter- and intramolecular interactions, but results in a relatively mild disease phenotype. Renal failure in an L1649R male typically occurs in the 4th or 5th decade and precedes the onset of significant hearing loss by approximately 10 years.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651292      PMCID: PMC1915056     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  40 in total

1.  Amplification of human polymorphic sites in the X-chromosomal region q21.33 to q24: DXS17, DXS87, DXS287, and alpha-galactosidase A.

Authors:  R Kornreich; K H Astrin; R J Desnick
Journal:  Genomics       Date:  1992-05       Impact factor: 5.736

2.  Two CA-dinucleotide polymorphisms at the COL4A5 (Alport syndrome) gene in Xq22.

Authors:  D F Barker; J Cleverly; P R Fain
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  Attachment of a 40-base-pair G + C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes.

Authors:  V C Sheffield; D R Cox; L S Lerman; R M Myers
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Localization of the highly polymorphic microsatellite DXS456 on the genetic linkage map of the human X chromosome.

Authors:  P R Fain; J A Luty; Z Guo; K Nguyen; D F Barker; M Litt
Journal:  Genomics       Date:  1991-12       Impact factor: 5.736

5.  Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome.

Authors:  J Zhou; D F Barker; S L Hostikka; M C Gregory; C L Atkin; K Tryggvason
Journal:  Genomics       Date:  1991-01       Impact factor: 5.736

6.  Mutation in the alpha 5(IV) collagen chain in juvenile-onset Alport syndrome without hearing loss or ocular lesions: detection by denaturing gradient gel electrophoresis of a PCR product.

Authors:  J Zhou; J M Hertz; K Tryggvason
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

7.  High-density genetic and physical mapping of DNA markers near the X-linked Alport syndrome locus: definition and use of flanking polymorphic markers.

Authors:  D F Barker; P R Fain; D E Goldgar; J N Dietz-Band; A E Turco; C E Kashtan; M C Gregory; K Tryggvason; M H Skolnick; C L Atkin
Journal:  Hum Genet       Date:  1991-12       Impact factor: 4.132

8.  Identification of a distinct type IV collagen alpha chain with restricted kidney distribution and assignment of its gene to the locus of X chromosome-linked Alport syndrome.

Authors:  S L Hostikka; R L Eddy; M G Byers; M Höyhtyä; T B Shows; K Tryggvason
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

9.  Retinal abnormalities in Alport's syndrome.

Authors:  O Gelisken; F Hendrikse; C H Schröder; J H Berden
Journal:  Acta Ophthalmol (Copenh)       Date:  1988-12

10.  The two Caenorhabditis elegans basement membrane (type IV) collagen genes are located on separate chromosomes.

Authors:  X D Guo; J M Kramer
Journal:  J Biol Chem       Date:  1989-10-15       Impact factor: 5.157

View more
  21 in total

1.  Genotype-phenotype correlation in X-linked Alport syndrome.

Authors:  Mir Reza Bekheirnia; Berenice Reed; Martin C Gregory; Kim McFann; Alireza Abdollah Shamshirsaz; Amirali Masoumi; Robert W Schrier
Journal:  J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 10.121

2.  Type IV procollagen missense mutations associated with defects of the eye, vascular stability, the brain, kidney function and embryonic or postnatal viability in the mouse, Mus musculus: an extension of the Col4a1 allelic series and the identification of the first two Col4a2 mutant alleles.

Authors:  Jack Favor; Christian Johannes Gloeckner; Dirk Janik; Martina Klempt; Angelika Neuhäuser-Klaus; Walter Pretsch; Wolfgang Schmahl; Leticia Quintanilla-Fend
Journal:  Genetics       Date:  2006-12-18       Impact factor: 4.562

Review 3.  Alport's syndrome.

Authors:  F Flinter
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

4.  Renal, auricular, and ocular outcomes of Alport syndrome and their current management.

Authors:  Yanqin Zhang; Jie Ding
Journal:  Pediatr Nephrol       Date:  2017-09-01       Impact factor: 3.714

5.  Ventricular septal defect in a child with Alport syndrome: a case report.

Authors:  Pier Paolo Bassareo; Andrea Raffaele Marras; Giuseppe Mercuro
Journal:  BMC Cardiovasc Disord       Date:  2010-10-05       Impact factor: 2.298

6.  Pediatric glomerular hematuria: a clinicopathological study.

Authors:  Fatma El-Husseiny Moustafa; Riham Eid; Nashwa Hamdy
Journal:  Clin Exp Nephrol       Date:  2020-03-20       Impact factor: 2.801

7.  Comparative analysis of the noncollagenous NC1 domain of type IV collagen: identification of structural features important for assembly, function, and pathogenesis.

Authors:  K O Netzer; K Suzuki; Y Itoh; B G Hudson; R G Khalifah
Journal:  Protein Sci       Date:  1998-06       Impact factor: 6.725

Review 8.  X-linked, COL4A5 hypomorphic Alport mutations such as G624D and P628L may only exhibit thin basement membrane nephropathy with microhematuria and late onset kidney failure.

Authors:  A Pierides; K Voskarides; M Kkolou; M Hadjigavriel; C Deltas
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

9.  Temporal macular thinning associated with X-linked Alport syndrome.

Authors:  Faisal Ahmed; Kandon K Kamae; Denise J Jones; Margaret M Deangelis; Gregory S Hageman; Martin C Gregory; Paul S Bernstein
Journal:  JAMA Ophthalmol       Date:  2013-06       Impact factor: 7.389

10.  Molecular testing for adult type Alport syndrome.

Authors:  Genevieve Pont-Kingdon; Kelli Sumner; Friederike Gedge; Chris Miller; Joyce Denison; Martin Gregory; Elaine Lyon
Journal:  BMC Nephrol       Date:  2009-11-17       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.